12/11 Yahoo! Finance: PFE News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Yahoo! Finance: PFE News - Latest Financial News for PFIZER INC Sens. move to block drugmakers from mining Rx data (AP) December 10, 2009 at 5:46 pm Drug companies would no longer be able to mine pharmacy records to track which doctors are prescribing their medications, under a proposal unveiled Thursday by two Senate Democrats. [video] Prop Desk (at CNBC) December 10, 2009 at 5:25 pm Eli Lilly predicts earnings growth, touts pipeline (AP) December 10, 2009 at 4:39 pm Eli Lilly & Co. said Thursday earnings per share could grow more than 10 percent next year, but the drugmaker's stock dropped as its 2009 forecast fell short of Wall Street expectations. A Tale of Two Lillys (at Motley Fool) December 10, 2009 at 4:12 pm Protalix Drug Advances (Zacks.com) December 10, 2009 at 3:50 pm The treatment for Gaucher disease has been granted orphan-drug designation and fast-track status by the FDA to facilitate its development. Bears Mauling This Drug Maker's Shares (at CNBC) December 10, 2009 at 3:46 pm Pfizer Cancer Drug Shows Breast Cancer Relapse Prevention (at Fox Business) December 10, 2009 at 3:35 pm [video] Growth Lessons: Making Mistakes Matter (at Forbes.com) December 10, 2009 at 2:57 pm Dreadful Stocks to Avoid (at Motley Fool) December 10, 2009 at 2:32 pm Pfizer extends medication giveaway for jobless (AP) December 10, 2009 at 2:03 pm Drugmaker Pfizer Inc. said Thursday it will extend for another year a program that provides free prescription medications to people who have lost their jobs. The Public Option Is Dead. Again. Maybe. (at Motley Fool) December 10, 2009 at 1:53 pm Pfizer Extends Commitment to Help Unemployed Americans (Business Wire) December 10, 2009 at 1:41 pm NEW YORK----Pfizer today announced it will extend its MAINTAIN™ patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer primary care medicines currently available through MAINTAIN, Pfizer will extend the benefits of MAINTAIN to many legacy Wyeth medicines. Eli Lilly's Prognosis: Uncertainty (at Minyanville.com) December 10, 2009 at 1:15 pm What happens when a patent cliff is within sight. UPDATE - Lilly suggests profit stumble after patent cliff (at Reuters) December 10, 2009 at 12:22 pm Eli Lilly predicts earnings growth, touts pipeline (AP) December 10, 2009 at 12:07 pm Eli Lilly & Co. said Thursday earnings per share could grow more than 10 percent next year, but the drugmaker's stock dipped as its 2009 forecast fell short of Wall Street expectations. Your Home Run Stocks May Actually Stink (at Motley Fool) December 10, 2009 at 11:59 am 4 Stocks to Benefit From Health Care Reform: Strategist (at CNBC) December 10, 2009 at 11:55 am Eli Lilly Ups 2010 Earnings Forecast (at Fox Business) December 10, 2009 at 11:51 am Pfizer Announces Updated Trial Results for AROMASIN® (exemestane tablets) In Switch And Upfront Settings (Business Wire) December 10, 2009 at 11:42 am SAN ANTONIO----Pfizer today announced results from an exploratory analysis of the Intergroup Exemestane Study at a median follow-up of 91 months in estrogen-receptor positive or estrogen-receptor unknown women that looked at breast cancer free survival and censored deaths that occurred prior to breast cancer relapse. Lilly suggests profit stumble after patent cliff (Reuters) December 10, 2009 at 10:21 am Eli Lilly and Co forecast 2010 earnings in line with Wall Street expectations, but suggested earnings could fall after its biggest drugs lose patent protection between 2011 and 2014. UPDATE - Glaxo plans to outgrow rivals in emerging markets (at Reuters) December 10, 2009 at 10:08 am 4-Star Stocks Poised to Pop: Kimberly-Clark (at Motley Fool) December 10, 2009 at 10:07 am Pfizer, Merck, Abbott and Lilly Deals in SEC Insider Trading Probe (at The Wall Street Journal Online) December 10, 2009 at 9:10 am Lilly forecasts sidestep 2011-2014 patent cliff (Reuters) December 10, 2009 at 8:29 am Eli Lilly and Co forecast 2010 earnings in line with Wall Street expectations but gave no hint of how profit might pan out after its biggest drugs lose patent protection between 2011 and 2014. UPDATE - Lilly forecasts sidestep 2011-2014 patent cliff (at Reuters) December 10, 2009 at 8:25 am Pfizer Extends Commitment to Help Unemployed Americans (Business Wire) December 10, 2009 at 8:00 am NEW YORK----Pfizer today announced it will extend its MAINTAIN™ patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer primary care medicines currently available through MAINTAIN, Pfizer will extend the benefits of MAINTAIN to many legacy Wyeth medicines. Pfizer May Raise Dividend by 20 Percent Later This Month (at Seeking Alpha) December 10, 2009 at 7:52 am SEC eyes 9 deals in insider trading probe: report (Reuters) December 10, 2009 at 7:45 am U.S. securities regulators are investigating at least nine mergers, including Pfizer Inc's takeover of Wyeth and Merck & Co Inc's acquisition of Schering-Plough Corp, for possible insider-trading violations, the Wall Street Journal reported, citing people familiar with the matter. U.S. SEC eyes 9 deals in insider trading probe-WSJ (at Reuters) December 10, 2009 at 7:41 am [$$] Lilly Sees More Growth in 2010 (at The Wall Street Journal Online) December 10, 2009 at 7:30 am   This email was sent to gatdemit001@gmail.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.